Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Renovacare Inc RCAR

RenovaCare, Inc. is a clinical-stage biotechnology company. The Company is focused on developing autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company through its wholly owned subsidiary, RenovaCare Sciences Corp. is focusing on the research, development and commercialization of autologous (using a patient’s own cells) cellular therapies that can be used for medical and aesthetic applications. The Company’s CellMist System is a cell isolation procedure that enzymatically renders stem cells from the patient’s own skin or other tissues. The resulting stem cell suspension is administered topically from the Company’s novel solution sprayer device (the SkinGun) as a cell therapy for wounds including burns to facilitate healing. Its SkinGun spray device is an advanced technology, using a gentle positive-pressure air stream to spray the CellMist Solution onto wounds.


GREY:RCAR - Post by User

Bullboard Posts
Post by oldtimer42on Feb 14, 2018 3:27pm
57 Views
Post# 27560267

Marking Time

Marking TimeI am not sure what impact this Streetsweeper blog has had on the stock. If you go to their website and read the writeup on Renovacare it characterizes management as crooks in the midst of a pump and dump and says they are looking to dump 4 million share make a $30+ million profit. It is all bogus supported by other losers on the internet supporting them to give them credibility. Unfortunately, many believe this drivel as they are looking to drive down the stock and sell short.

This all may account for the sluggish trading lately. I doubt we will break out of this range until RCAR tenders their FDA application. They have taken far to long to accomplish this which gives rise to these bozos, the short sellers and it enboldens them.

I hope management now have the message to speed it up and get it done.
Bullboard Posts